MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Antiplatelet Therapy and Cardiovascular Diseases
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,498 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,498 works in the cohort · of 4,299,418page 17 of 30

Labels cover 9 of 1,498 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,498 of 1,498 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

venueno affunlabeled
Clopidogrel and proton pump inhibitors
Deepak L. Bhatt
2014· letter· en· Canadian Medical Association Journal· Medicine
machine prediction:candidate · noneconsensus · none
4
citations
affno abstractunlabeled
CHARISMA
Marc Fisher, Kennedy R. Lees, John W. Norris, Henry J.M. Barnett
2006· article· en· Stroke· Medicine
machine prediction:candidate · noneconsensus · none
4
citations
affunlabeled
Antithrombotic therapy after coronary artery bypass graft surgery: a Clinical Consensus Statement of the ESC Working Group on Cardiovascular Surgery, the ESC Working Group on Cardiovascular Pharmacotherapy, and the European Association for Cardio-Thoracic Surgery (EACTS)
Sigrid Sandner, Mario Gaudino, Stefan Agewall, Giorgia Bonalumi, Nikolaos Bonaros, Martin Czerny +10 more
2025· review· en· European Journal of Cardio-Thoracic Surgery· Medicine
machine prediction:candidate · noneconsensus · none
4
citations
affno abstractunlabeled
Health-related quality of life outcomes with prasugrel among medically managed non–ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial
Padma Kaul, E. Magnus Ohman, J. David Knight, Kevin J. Anstrom, Matthew T. Roe, William E. Boden +12 more
2016· article· en· American Heart Journal· Medicine
machine prediction:candidate · noneconsensus · none
4
citations
afffundaboutunlabeled
Contemporary use of <scp>guideline‐based</scp> higher potency <scp>P2Y12</scp> receptor inhibitor therapy in patients with <scp>moderate‐to‐high</scp> risk <scp>non‐ST‐segment</scp> elevation myocardial infarction: Results from the Canadian <scp>ACS</scp> reflective <scp>II cross‐sectional</scp> study
Ashish Patel, Shaun G. Goodman, Mary Tan, Neville Suskin, Robert S. McKelvie, Andrew Mathew +22 more
2021· article· en· Clinical Cardiology· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
aboutno affunlabeled
Antiplatelet Agents for Stroke Prevention
Maurizio Paciaroni, Virgilio Gallai
2000· review· en· Cerebrovascular Diseases· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
venueno affno abstractunlabeled
ISCHEMIC AND BLEEDING OUTCOMES AFTER CORONARY ARTERY BYPASS GRAFTING AMONG PATIENTS INITIALLY TREATED WITH A P2Y12 RECEPTOR ANTAGONIST FOR ACUTE CORONARY SYNDROMES - INSIGHTS ON TIMING OF DISCONTINUATION OF TICAGRELOR AND CLOPIDOGREL PRIOR TO SURGERY
Juan Russo, Tyler E. James, Marc Ruel, Jean‐Yves Dupuis, Kamaljot Singh, Daniel Goubran +11 more
2016· article· en· Canadian Journal of Cardiology· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affvenueno abstractunlabeled
Review of the top 5 cardiology studies of 2017-18
Arden R. Barry, Hazal E. Babadagli, June W. Chen, Taryn A. May, Chloe L. McMillan, Mohamed A. Omar +3 more
2019· review· en· Canadian Pharmacists Journal / Revue des Pharmaciens du Canada· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affvenueno abstractunlabeled
Guidelines for Antithrombotic Therapy
Rubina Sunderji
2001· article· en· The Canadian Journal of Hospital Pharmacy· Medicine
machine prediction:candidate · noneconsensus · none
3
citations

How this was built: Screen · Findings · About